RUBATTO, MARCO

RUBATTO, MARCO  

SCIENZE MEDICHE  

Mostra records
Risultati 1 - 20 di 35 (tempo di esecuzione: 0.015 secondi).
Titolo Data di pubblicazione Autore(i) File
Acute appendicitis secondary to desmoplastic melanoma metastasis in immune-checkpoint inhibitors era 2021 Avallone, Gianluca; Astrua, Chiara; Fava, Paolo; Tonella, Luca; Mastorino, Luca; Agostini, Andrea; Merli, Martina; Rubatto, Marco; De Pasquale, Rocco; Conti, Luca; Quaglino, Pietro; Ribero, Simone
Addendum: Immunotherapy in Xeroderma Pigmentosum: a case of advanced cutaneous squamous cell carcinoma treated with cemiplimab and a literature review 2022 Rubatto, Marco; Merli, Martina; Avallone, Gianluca; Agostini, Andrea; Mastorino, Luca; Caliendo, Virginia; Barcellini, Amelia; Vitolo, Viviana; Valvo, Francesca; Fierro, Maria Teresa; Ribero, Simone; Quaglino, Pietro
Anti-BRAF/anti-MEK targeted therapies for metastatic melanoma patients during the COVID-19 outbreak: Experience from an Italian skin cancer unit 2021 Quaglino P.; Fava P.; Brizio M.; Marra E.; Rubatto M.; Merli M.; Tonella L.; Ribero S.; Fierro M.T.
Association between Primary Cutaneous B-cell Lymphomas and Other Skin Cancers: A Multicentre Cohort Study 2022 Avallone G.; Roccuzzo G.; Torres-Navarro I.; Gelato F.; Mastorino L.; Agostini A.; Merli M.; Cavallo F.; Rubatto M.; Senetta R.; Botella Estrada R.; Ribero S.; Quaglino P.
Biologic treatment for psoriasis in cancer patients: should they still be considered forbidden? 2021 Mastorino L.; Dapavo P.; Avallone G.; Merli M.; Cariti C.; Rubatto M.; Pala V.; Quaglino P.; Ribero S.
Case Report: Atypical Cutaneous Presentation of Human T-cell Lymphotropic Virus Type 1-Related Adult T-cell Lymphoma 2021 Avallone, Gianluca; Trunfio, Mattia; Mastorino, Luca; Agostini, Andrea; Merli, Martina; Rubatto, Marco; Caracciolo, Daniele; Calcagno, Andrea; Senetta, Rebecca; Fierro, Maria Teresa; Quaglino, Pietro; Ribero, Simone
Clinical evaluation of hydration index using a corneometer in metastatic melanoma patients treated with BRAF/MEK inhibitors: a prospective study 2022 Amabile, Simone; Tonella, Luca; Rubatto, Marco; Argenziano, Giuseppe; Babino, Graziella; Frascione, Pasquale; Dika, Emi; Giacomelli, Luca; Parodi, Aurora; Quaglino, Pietro
Clinical significance of distant metastasis-free survival (Dmfs) in melanoma: A narrative review from adjuvant clinical trials 2021 Amabile S.; Roccuzzo G.; Pala V.; Tonella L.; Rubatto M.; Merli M.; Fava P.; Ribero S.; Fierro M.T.; Queirolo P.; Quaglino P.
Cutaneous side effects and types of dermatological reactions in metastatic melanoma patients treated by immunotherapies or targeted therapies: A retrospective single center study 2022 Gullo G.; Rubatto M.; Fava P.; Brizio M.; Tonella L.; Ribero S.; Medri M.; Avallone G.; Mastorino L.; Fierro M.T.; Stanganelli I.; Quaglino P.
Data of Italian Cancer Centers from two regions with high incidence of SARS CoV-2 infection provide evidence for the successful management of patients with locally advanced and metastatic melanoma treated with immunotherapy in the era of COVID-19 2020 Pala L.; Conforti F.; Saponara M.; De Pas T.; Giugliano F.; Omodeo Sale E.; Jemos C.; Rubatto M.; Agostini A.; Quaglino P.; Fava P.; Fierro M.T.; Queirolo P.
Extensive "halo naevi" phenomenon and regression of melanin during nivolumab treatment in metastatic melanoma: A predictor of a better outcome? 2022 Cavallo, Francesco; Roccuzzo, Gabriele; Avallone, Gianluca; Conforti, Claudio; Zalaudek, Iris; Giordano, Silvia; Rubatto, Marco; Fava, Paolo; Ribero, Simone; Quaglino, Pietro
Immunotherapy in transplanted patients: A special population that can no longer be ignored 2021 Rubatto M.; Merli M.; Agostini A.; Avallone G.; Mastorino L.; Fava P.; Biancone L.; Rossetti M.; Fierro M.T.; Ribero S.; Quaglino P.
Immunotherapy in Xeroderma Pigmentosum: A case of advanced cutaneous squamous cell carcinoma treated with cemiplimab and a literature review 2021 Rubatto M.; Merli M.; Avallone G.; Agostini A.; Mastorino L.; Caliendo V.; Barcellini A.; Vitolo V.; Valvo F.; Fierro M.T.; Ribero S.; Quaglino P.
Liver metastases and immunotherapy: A barrier to response for metastatic melanoma 2023 Marco Rubatto; Nicole Macagno; Ginevra Pastorin; Paolo Fava; Luca Ceroni; Simone Ribero; Pietro Quaglino
Melanoma management during the covid-19 pandemic emergency: A literature review and single-center experience 2021 Cariti C.; Merli M.; Avallone G.; Rubatto M.; Marra E.; Fava P.; Caliendo V.; Picciotto F.; Gualdi G.; Stanganelli I.; Fierro M.T.; Ribero S.; Quaglino P.
Metastatic melanoma treatment with checkpoint inhibitors in the COVID-19 era: experience from an Italian Skin Cancer Unit 2020 Quaglino P.; Fava P.; Brizio M.; Marra E.; Rubatto M.; Agostini A.; Tonella L.; Ribero S.; Fierro M.T.
Misuse, consequences and phototoxic skin-related effects of Rutaceae: a comprehensive literature review 2021 Avallone, Gianluca; Mastorino, Luca; Agostini, Andrea; Merli, Martina; Siliquini, Niccolò; Rubatto, Marco; Fierro, Maria Teresa; Ribero, Simone; Quaglino, Pietro
Nonmelanoma skin cancer arising on tattoos 2022 Rubatto, Marco; Gelato, Federica; Mastorino, Luca; Giordano, Silvia; Ribero, Simone; Quaglino, Pietro
Patients with locally advanced and metastatic cutaneous squamous cell carcinoma treated with immunotherapy in the era of COVID-19: stop or go? Data from five Italian referral cancer centers 2020 Saponara M.; Pala L.; Conforti F.; Rubatto M.; De Risi I.; Spagnolo F.; Guida M.; Bossi P.; Quaglino P.; Queirolo P.
Patients with psoriasis resistant to multiple biological therapies: characteristics and definition of a difficult-to-treat population 2022 Mastorino L.; Roccuzzo G.; Dapavo P.; Siliquini N.; Avallone G.; Rubatto M.; Merli M.; Agostini A.; Ribero S.; Quaglino P.